ID: ALA123619

Max Phase: Preclinical

Molecular Formula: C8H13N3O2

Molecular Weight: 183.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCNc1cc(O)nc(O)n1

Standard InChI:  InChI=1S/C8H13N3O2/c1-2-3-4-9-6-5-7(12)11-8(13)10-6/h5H,2-4H2,1H3,(H3,9,10,11,12,13)

Standard InChI Key:  VTYJBXCNELPXNP-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 183.21Molecular Weight (Monoisotopic): 183.1008AlogP: 1.10#Rotatable Bonds: 4
Polar Surface Area: 78.27Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.75CX Basic pKa: 1.52CX LogP: 2.11CX LogD: 2.09
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.61Np Likeness Score: -1.08

References

1. Wright GE, Brown NC..  (1980)  Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.,  23  (1): [PMID:6767030] [10.1021/jm00175a007]

Source